HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 564 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $302,761 | +12.0% | 2,617 | -0.5% | 0.02% | +8.7% |
| Q2 2023 | $270,393 | -77.3% | 2,629 | -75.9% | 0.02% | -68.5% |
| Q1 2023 | $1,190,063 | -9.3% | 10,904 | -5.4% | 0.07% | -15.1% |
| Q4 2022 | $1,311,545 | +55.8% | 11,525 | -15.3% | 0.09% | +56.4% |
| Q3 2022 | $842,000 | +5.0% | 13,605 | +35.3% | 0.06% | +27.9% |
| Q2 2022 | $802,000 | +125.3% | 10,057 | +204.4% | 0.04% | +95.5% |
| Q4 2021 | $356,000 | +52.8% | 3,304 | +55.5% | 0.02% | +69.2% |
| Q3 2021 | $233,000 | -21.3% | 2,125 | -33.9% | 0.01% | -23.5% |
| Q1 2021 | $296,000 | -84.5% | 3,213 | -86.9% | 0.02% | -72.6% |
| Q3 2020 | $1,910,000 | -25.3% | 24,591 | -46.6% | 0.06% | -6.1% |
| Q2 2020 | $2,558,000 | -12.2% | 46,025 | -53.2% | 0.07% | -14.3% |
| Q1 2020 | $2,915,000 | -57.6% | 98,420 | -48.2% | 0.08% | -19.8% |
| Q4 2019 | $6,873,000 | +494.0% | 189,854 | +347.0% | 0.10% | +585.7% |
| Q3 2019 | $1,157,000 | – | 42,474 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |